Powered by TradingView

Company Profile

Onxeo SA is engaged in the development of drugs for the treatment of orphan diseases in particular in oncology. Its pipeline products include AsiDNA 1V, AsiDNA+chemo/radio, AsiDNA+Belinostat/HDACi and others.
Key Stats
Website http://www.onxeo.com
Headquarter country France
Employees 53
Market Cap (at close 13-07-2018) DKK 483M
Morningstar Sector
Morningstar Industry
Stock Style
Fiscal Year Ends december
Board of Directors

Copyright Euroinvestor A/S 2018  Disclaimer  |  Cookie- og privatlivspolitik  |  Persondatapolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
16. juli 2018 18:06:18
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20180712.1 - EUROWEB2 - 2018-07-16 18:06:18 - 2018-07-16 18:06:18 - 1 - Website: OKAY